Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Ovarian Neoplasms

Free Subscription Articles published in Am J Obstet Gynecol Retrieve available abstracts of 38 articles: HTML format

Single Articles

February 2026
1. GANESAN S, Mansour L, Dibden A, Sideris M, et al
   Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.
   Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00084.
   PubMed     Abstract available
   
   
   December 2025
2. MORO F, Momi M, Ledger A, Barrenada L, et al
   External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6).
   Am J Obstet Gynecol. 2025;233:629.
   PubMed     Abstract available
   
   
   November 2025
3. KANBERGS A, Agusti N, Perkins G, Wu CF, et al
   Trends and Clinical Predictors in Ovarian Preservation in Patients with Low-Risk Endometrial Cancer.
   Am J Obstet Gynecol. 2025 Nov 10:S0002-9378(25)00829.
   PubMed     Abstract available
   
   
   
4. WILKE RN, Pennington KP, Gootzen TA, Steenbeek MP, et al
   Salpingectomy in individuals at high risk for tubo-ovarian cancer - consensus and precaution.
   Am J Obstet Gynecol. 2025 Nov 1:S0002-9378(25)00820.
   PubMed     Abstract available
   
   
   October 2025
5. KALRA A, Ganesan S, Sia JJY, Papalois KB, et al
   Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.
   Am J Obstet Gynecol. 2025;233:276-291.
   PubMed     Abstract available
   
   
   September 2025
6. MEYER LA, Ishizawa S, Toumazis I
   Use of a Natural History Model to Benchmark Progress in Managing Ovarian Cancer (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00658.
   PubMed    
   
   
   
7. MENG R
   Enhancing Clinical Translatability of Histology-Specific Ovarian Cancer Natural History Models (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00659.
   PubMed    
   
   
   July 2025
8. ISHIZAWA S, Eghbalizarch M, Nargund RS, Sarayi SMMJ, et al
   Development and Validation of a Histology-Specific Natural History Model of Ovarian Cancer.
   Am J Obstet Gynecol. 2025 Jul 4:S0002-9378(25)00459.
   PubMed     Abstract available
   
   
   
9. BRODSKY AL, Flores Legarreta A, How JA, Vuttaradhi V, et al
   Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors.
   Am J Obstet Gynecol. 2025;233:51.
   PubMed     Abstract available
   
   
   June 2025
10. GOOTZEN TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, et al
    Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study.
    Am J Obstet Gynecol. 2025 Jun 16:S0002-9378(25)00400.
    PubMed     Abstract available
    
    
    May 2025
11. GUZEL HG, Balcik OY, Ilhan Y
    Reshaping the Landscape of Ovarian Cancer: Implications from the Surgery for Ovarian cancer FIGO 4 Study.
    Am J Obstet Gynecol. 2025 May 4:S0002-9378(25)00294.
    PubMed    
    
    
    
12. JOCHUM F, Akladios C
    Primary vs interval cytoreductive surgery in stage IV ovarian cancer (SOFI-4).
    Am J Obstet Gynecol. 2025 May 3:S0002-9378(25)00295.
    PubMed    
    
    
    April 2025
13. XU X, Long JB, Pollack CE, Desai VB, et al
    Peer Influence on Physicians in Adopting Opportunistic Salpingectomy at the Time of Hysterectomy.
    Am J Obstet Gynecol. 2025 Apr 18:S0002-9378(25)00229.
    PubMed     Abstract available
    
    
    January 2025
14. KARSTENSEN S, Jochumsen K, Hogdall C, Hogdall E, et al
    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers.
    Am J Obstet Gynecol. 2025 Jan 21:S0002-9378(25)00029.
    PubMed     Abstract available
    
    
    December 2024
15. WU P, Zhou J, Zhang Y
    Incorporation of BRCA1 testing into prenatal carrier screening for hereditary breast and ovarian cancer prevention should take carrier rates into account.
    Am J Obstet Gynecol. 2024 Dec 11:S0002-9378(24)01181.
    PubMed    
    
    
    October 2024
16. TANKOU J, Foley OW, Liu CY, Melamed A, et al
    Dermoid cyst management and outcomes: a review of over 1000 cases at a single institution.
    Am J Obstet Gynecol. 2024;231:442.
    PubMed     Abstract available
    
    
    August 2024
17. ADJEI NN, Haas AM, Sun CC, Zhao H, et al
    Cost of ovarian cancer by the phase of care in the United States.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00846.
    PubMed     Abstract available
    
    
    
18. JOCHUM F, Dumas E, Gougis P, Hamy AS, et al
    Survival Outcomes of Primary versus Interval Cytoreductive Surgery for FIGO IV Ovarian Cancer (SOFI-4): a Nationwide Population-based Target Trial Emulation.
    Am J Obstet Gynecol. 2024 Aug 5:S0002-9378(24)00818.
    PubMed     Abstract available
    
    
    July 2024
19. SUZUKI Y, Ferris JS, Chen L, Dioun S, et al
    Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2024 Jul 18:S0002-9378(24)00761.
    PubMed     Abstract available
    
    
    
20. MORO F, Pinto AP, Chiappa V, Testa AC, et al
    Prediction of non-resectability using the updated Predictive Index Value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.
    Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00740.
    PubMed     Abstract available
    
    
    June 2024
21. WIJAYABAHU AT, Shiels M, Arend RC, Clarke MA, et al
    Uterine Cancer Incidence Trends and Five-Year Relative Survival by Race/Ethnicity and Histology Among Women Under 50 Years.
    Am J Obstet Gynecol. 2024 Jun 24:S0002-9378(24)00694.
    PubMed     Abstract available
    
    
    May 2024
22. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    PubMed     Abstract available
    
    
    April 2024
23. SUH-BURGMANN EJ, Hung YY, Schmittdiel JA
    Ovarian cancer risk among older patients with stable adnexal masses.
    Am J Obstet Gynecol. 2024 Apr 23:S0002-9378(24)00525.
    PubMed     Abstract available
    
    
    
24. DIOUN SM, Perez LR, Prabhu M, Brewer JT, et al
    Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
    Am J Obstet Gynecol. 2024 Apr 13:S0002-9378(24)00520.
    PubMed     Abstract available
    
    
    March 2024
25. LEE MW, Vallejo A, Furey KB, Woll SM, et al
    Racial and ethnic differences in early-death among gynecologic malignancy.
    Am J Obstet Gynecol. 2024 Mar 7:S0002-9378(24)00432.
    PubMed     Abstract available
    
    
    
26. LU J, Guo Q, Zhang Y, Zhao S, et al
    A modified diffusion-weighted MRI-based model from the radiologist's perspective: improved performance in determining the surgical resectability for advanced high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2024 Mar 1:S0002-9378(24)00415.
    PubMed     Abstract available
    
    
    January 2024
27. HOW JA, Legarreta AF, Handley KF, Fellman B, et al
    Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2024 Jan 6:S0002-9378(24)00009.
    PubMed     Abstract available
    
    
    September 2023
28. JONSSON S, Jonsson H, Lundin E, Haggstrom C, et al
    Pelvic inflammatory disease and risk of epithelial ovarian cancer. A national population-based case-control study in Sweden.
    Am J Obstet Gynecol. 2023 Sep 29:S0002-9378(23)00723.
    PubMed     Abstract available
    
    
    
29. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
    Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
    PubMed     Abstract available
    
    
    August 2023
30. ZHOU J, Wu P, Zhang Y
    Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast/ovarian cancer.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00597.
    PubMed    
    
    
    
31. WEI X, Oxley S, Sideris M, Legood R, et al
    Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: Response.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00598.
    PubMed    
    
    
    June 2023
32. BLUSTEIN P, Werner SR, Uppalapati P, Leung TM, et al
    Adherence to Risk-Reducing Salpingo-Oophorectomy Guidelines Among Gynecologic Oncologists Compared to General Gynecologists.
    Am J Obstet Gynecol. 2023 Jun 10:S0002-9378(23)00380.
    PubMed     Abstract available
    
    
    April 2023
33. GOMEZ SL, Mcguire V, Collin LJ, Dempsey L, et al
    Disparities in ovarian cancer survival: does place matter?
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00263.
    PubMed     Abstract available
    
    
    
34. WEI X, Oxley S, Sideris M, Kalra A, et al
    Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2023 Apr 12:S0002-9378(23)00240.
    PubMed     Abstract available
    
    
    
35. TERRA L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, et al
    Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
    Am J Obstet Gynecol. 2023;228:440.
    PubMed     Abstract available
    
    
    March 2023
36. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed     Abstract available
    
    
    
37. FOSTER KI, Flores Legarreta A, Kamat R, Handley KF, et al
    Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00148.
    PubMed     Abstract available
    
    
    November 2022
38. CATHCART AM, Nezhat FR, Emerson J, Pejovic T, et al
    Adnexal masses during pregnancy: diagnosis, treatment and prognosis.
    Am J Obstet Gynecol. 2022 Nov 18:S0002-9378(22)02179.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum